Publications in collaboration with researchers from Complexo Hospitalario Universitario de Santiago (19)

2024

  1. Discrepancies in the results reported for multiple sclerosis clinical trials: A comparison between ClinicalTrials.gov and peer-reviewed journals

    Multiple Sclerosis Journal

2021

  1. A family-based study to identify genetic biomarkers of fibromyalgia: consideration of patients' subgroups

    Clinical and experimental rheumatology, Vol. 39, Núm. 3, pp. 144-152

2020

  1. Antihyperthermic treatment decreases perihematomal hypodensity

    Neurology, Vol. 94, Núm. 16, pp. E1738-E1748

  2. Intra- and extra-hospital improvement in ischemic stroke patients: influence of reperfusion therapy and molecular mechanisms

    Scientific Reports, Vol. 10, Núm. 1

  3. NT-pro-BNP: A novel predictor of stroke risk after transient ischemic attack

    International Journal of Cardiology, Vol. 298, pp. 93-97

  4. Regulatory T cells participate in the recovery of ischemic stroke patients

    BMC Neurology, Vol. 20, Núm. 1

2019

  1. Influence of Sex on Stroke Prognosis: A Demographic, Clinical, and Molecular Analysis

    Frontiers in Neurology, Vol. 10

  2. Shape effect in active targeting of nanoparticles to inflamed cerebral endothelium under static and flow conditions

    Journal of Controlled Release, Vol. 309, pp. 94-105

2015

  1. Convergence between the 1990 and 2010 ACR diagnostic criteria and validation of the Spanish version of the Fibromyalgia Survey Questionnaire (FSQ)

    Rheumatology International, Vol. 35, Núm. 1, pp. 141-151

  2. Long Survival and Severe Toxicity under 5-Fluorouracil-Based Therapy in a Patient with Colorectal Cancer Who Harbors a Germline Codon-Stop Mutation in TYMS

    Mayo Clinic Proceedings, Vol. 90, Núm. 9, pp. 1298-1303

2014

  1. A novel stop mutation in the vascular endothelial growth factor-C gene (VEGFC) results in Milroy-like disease

    Journal of Medical Genetics, Vol. 51, Núm. 7, pp. 475-478

2012

  1. The value of genetic polymorphisms to predict toxicity in metastatic colorectal patients with irinotecan-based regimens

    Cancer Chemotherapy and Pharmacology, Vol. 69, Núm. 6, pp. 1591-1599

  2. X-ray cross-complementing group 1 and thymidylate synthase polymorphisms might predict response to chemoradiotherapy in rectal cancer patients

    International Journal of Radiation Oncology Biology Physics, Vol. 82, Núm. 1, pp. 138-144

2011

  1. Evolutionary analyses of entire genomes do not support the association of mtdna mutations with ras/mapk pathway syndromes

    PLoS ONE, Vol. 6, Núm. 4

  2. Use of a comprehensive panel of biomarkers to predict response to a fluorouracil-oxaliplatin regimen in patients with metastatic colorectal cancer

    Pharmacogenomics, Vol. 12, Núm. 3, pp. 433-442

2010

  1. Influence of early dialysis among patients with advanced chronic renal disease: Results of a systematic review

    Nephrology Dialysis Transplantation, Vol. 25, Núm. 8, pp. 2414-2421

  2. La ocupación como factor de riesgo del cáncer oral y de faringe

    Acta Otorrinolaringologica Espanola

  3. Pharmacogenetic analysis in neoadjuvant chemoradiation for rectal cancer: High incidence of somatic mutations and their relation with response

    Pharmacogenomics, Vol. 11, Núm. 6, pp. 747-761

2003

  1. Self-rated health in the elderly and 5-year mortality. Study in a rural community

    Revista Espanola de Geriatria y Gerontologia, Vol. 38, Núm. 6, pp. 311-315